Dr. Kasem S. Akhras VantEdge Access LLC, USA

Kasem S. Akhras, PharmD, is a senior biopharma executive and advisor with over 30 years of global experience in market access, pricing, reimbursement, HEOR, and commercial strategy. He advises biotech companies and investors on pre-launch strategy and launch strategy for Phase II–III assets, focusing on evidence generation, HTA positioning, and... read morepricing to maximize asset value and reduce reimbursement risk. Dr. Akhras has held leadership roles at Novartis, AstraZeneca, Takeda, Pfizer, and Johnson & Johnson, most recently leading Global Value & Access at Novartis Gene Therapies for New Product Development. He is CEO and Co-Founder of VantEdge Access, a specialized market access consultancy supporting diligence, valuation, and commercialization strategy for innovative therapies, including gene and rare disease treatments.